Abstract | OBJECTIVE: RESEARCH DESIGN AND METHODS: We determined the prevalence of the: -75-bp and +83-bp polymorphisms of the apo(a1) gene by restriction fragment length polymorphism analysis among 308 unrelated nondiabetic subjects with CHD and among 251 unrelated patients with type 2 diabetes with CHD and in randomly selected 82 healthy men (CHD-). RESULTS: The rare M1- and M2- allele frequencies of the apo(a1) gene were 23 and 1.8%, respectively, among control subjects; 20 and 1.5%, respectively, among nondiabetic subjects with CHD; and 22 and 2.6%, respectively, among patients with type 2 diabetes and CHD (NS). Nonsmoking nondiabetic subjects with CHD having the M2+- genotype had higher HDL cholesterol (1.48 +/- 0.19 vs. 1.23 +/- 0.02 mmol/l, P < 0.01) and apo(a1) (1.43 +/- 0.10 vs. 1.36 +/- 0.02 g/l, P < 0.05) levels than subjects with the M2++ genotype, even after adjustment for confounding factors. This association was not found among patients with type 2 diabetes and CHD. CONCLUSIONS:
|
Authors | A Pulkkinen, L Viitanen, A Kareinen, S Lehto, M Laakso |
Journal | Diabetes care
(Diabetes Care)
Vol. 23
Issue 6
Pg. 791-5
(Jun 2000)
ISSN: 0149-5992 [Print] United States |
PMID | 10840998
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoprotein A-I
- Apolipoproteins B
- Blood Glucose
- Cholesterol, HDL
- Triglycerides
- Deoxyribonuclease HpaII
|
Topics |
- Apolipoprotein A-I
(blood, genetics)
- Apolipoproteins B
(blood)
- Blood Glucose
(metabolism)
- Blood Pressure
- Cholesterol, HDL
(blood)
- Coronary Disease
(blood, genetics, physiopathology)
- Deoxyribonuclease HpaII
- Diabetes Mellitus, Type 2
(blood, genetics, physiopathology)
- Diabetic Angiopathies
(blood, genetics, physiopathology)
- Female
- Genotype
- Humans
- Introns
- Male
- Middle Aged
- Polymorphism, Restriction Fragment Length
- Reference Values
- Triglycerides
(blood)
|